ABSTRACT
Background:
Carbapenem-resistant Acinetobacter baumannii (CRAB) is a growing threat to public health.
Methods:
A 3-year retrospective study was conducted to evaluate the prevalence and lethality of multidrug-resistant (MDR) A. baumannii isolated from Brazilian patients.
Results:
In this study, 219 Acinetobacter baumannii isolates were identified, of which 70.8% (155/219) were isolated from patients hospitalized in intensive care units. Of these, 57.4% (n = 89/155) were assessed, of which 92.1% (82/89) were carbapenem-resistant, and 49 were classified as infected. The lethality rate was 79.6% (39/49).
Conclusions:
We highlight the need of an effective epidemiological surveillance measure to contain the dissemination of CRAB in the hospital environment.
Keywords:
Acinetobacter baumannii; Carbapenem-resistant; Epidemiology; Surveillance; Lethality